Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has issued an announcement.
ASKA Pharmaceutical Holdings Co., Ltd. has reiterated its request to Dalton Investments and others to provide necessary information regarding their large-scale purchase of ASKA’s share certificates. Despite guidelines emphasizing transparency in corporate takeovers, Dalton has not complied, leading to concerns about the impact on shareholder decision-making and the company’s strategic options.
The most recent analyst rating on (JP:4886) stock is a Buy with a Yen2732.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is based in Tokyo and is involved in the large-scale purchase of company share certificates.
Average Trading Volume: 62,719
Technical Sentiment Signal: Buy
Current Market Cap: Yen64.08B
See more insights into 4886 stock on TipRanks’ Stock Analysis page.